Oral health condition in cancer patients under bisphosphonate therapy-Reference-Cited by-同舟云学术

Oral health condition in cancer patients under bisphosphonate therapy

Published:2021-06-18 Issue:12 Volume:29 Page:7687-7694
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Jardim Caldas Rogério^ORCID,Spíndola Antunes Héliton^ORCID,de Oliveira Rodini Pegoraro Camila^ORCID,Ribeiro Guedes Fábio,da Silva Santos Paulo Sérgio^ORCID

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-021-06362-y.pdf

Reference40 articles.

1. Wan JT, Sheeley DM, Somerman MJ, Lee JS (2020) Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors. Bone Res 8:1–12. https://doi.org/10.1038/s41413-020-0088-1

2. Nicolatou-Galitis O, Papadopoulou E, Vardas E, Kouri M, Galiti D, Galitis E, Alexiou KE, Tsiklakis K, Ardavanis A, Razis E, Athanasiadis I, Droufakou S, Psyrri A, Karamouzis MV, Linardou H, Daliani D, Tzanninis D, Sachanas S, Laschos K, Kyrtsonis MC, Antoniou F, Laskarakis A, Giassas S, Nikolaidi A, Rigakos G, Ntokou A, Migliorati CA, Ripamonti CI (2020) Alveolar bone histological necrosis observed prior to extractions in patients, who received bone-targeting agents. Oral Dis 26:955–966. https://doi.org/10.1111/odi.13294

3. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F (2014) American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw—2014. J Oral and Maxillofac Surg 72:1938–1956. https://doi.org/10.1016/j.joms.2014.04.031

4. Soares MQS, Van Dessel J, Jacobs R, da Silva Santos PS, Cestari TM, Garlet GP, Duarte MAH, Imada TSN, Lambrichts I, Rubira-Bullen IRF (2018) Zoledronic acid induces site-specific structural changes and decreases vascular area in the alveolar bone. J Oral and Maxillofac Surg 76:1893–1901. https://doi.org/10.1016/j.joms.2018.03.007

5. Katsarelis H, Shah NP, Dhariwal DK, Pazianas M (2015) Infection and medication-related osteonecrosis of the jaw. J Dental Res 94:534–539. https://doi.org/10.1177/0022034515572021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Bisphosphonate Therapy on Oral Health in Patients with Breast and Prostate Cancer and Bone Metastases: A Comprehensive Study;Cancers;2024-03-11

2. Oral Hygiene, Dental Status, and Quality of Life in cancer patients with Medication related osteonecrosis of the jaws- A cross sectional study: Part 2.;2024-02-12

3. Emerging antiresorptive medications and their potential implications for dental surgeries;The Journal of the American Dental Association;2022-07

4. One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost–benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ);Supportive Care in Cancer;2022-03-21

5. Review of Myeloma Therapies and Their Potential for Oral and Maxillofacial Side Effects;Cancers;2021-09-06